{"url_path":"/sec/bgms/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1130166/0001493152-26-023800-index.html","accession_number":"0001493152-26-023800","cik":"0001130166","ticker":"BGMS","issuer_name":"Bio Green Med Solution, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1130166/0001493152-26-023800-index.html","primary_entity_key":"0001130166","primary_entity_name":"Bio Green Med Solution, Inc."},"word_count":242,"has_tables":true,"body_markdown":"**Item\n6. Exhibits**\n\n \n\n**Exhibit\nNumber**\n \n**Description**\n\n31.1*\n \n[Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a) As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-1.htm)\n\n31.2*\n \n[Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a) As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-2.htm)\n\n32.1*\n \n[Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm)\n\n32.2*\n \n[Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-2.htm)\n\n101\n \nThe following materials\nfrom Bio Green Med Solution, Inc.’s Quarterly Report on Form 10-Q for the period ended March 31, 2026, formatted in iXBRL (Inline\neXtensible Business Reporting Language): (i) the Consolidated Statements of Income, (ii) the Consolidated Balance Sheets, (iii) the\nConsolidated Statements of Cash Flows, and (iv) Notes to Consolidated Financial Statements.\n\n104\n \nThe cover page from the\nCompany’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in Inline eXtensible Business Reporting\nLanguage (included with Exhibit 101).\n\n \n \n \n\n \n*\nFiled herewith.\n\n \n#\nManagement contract or compensatory plans or agreements.\n\n \n\n25\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed\non its behalf by the undersigned.\n\n \n\n \n**BIO GREEN MED SOLUTION, INC.**\n\n \n \n\nDate: May 15, 2026\nBy:\n*/s/\nDatuk Dr. Doris Wong*\n\n \n \nDatuk Dr. Doris Wong\n\n \n \nChief Executive Officer and Executive Director\n\n \n\n26"}